Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease
- 1 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular and Cellular Biochemistry
- Vol. 469 (1-2), 29-39
- https://doi.org/10.1007/s11010-020-03725-7
Abstract
Bac Coronary artery disease (CAD) is the leading cause of death worldwide and most commonly develops as a result of atherosclerosis. ANGPTL8 is a secreted adipokine that regulates lipid metabolism and is associated with cardiometabolic diseases, including type 2 diabetes and CAD. However, the association between circulating ANGPTL8 levels and CAD is inconsistent among studies and the mechanism by which ANGPTL8 contributes to CAD development remains poorly understood. Here we sought to evaluate the relationship between ANGPTL8 levels and endothelial dysfunction and adipose tissue inflammation in CAD patients. Concentrations of ANGPTL8, adiponectin, TNF-alpha, IL6, hsCRP, ICAM-1, and VCAM-1 were measured by ELISA in serum samples from 192 CAD patients diagnosed with stenosis > 50% in at least one coronary artery by angiography and 71 individuals with normal heart function. Serum ANGPTL8 levels were significantly higher in CAD patients compared to controls (83.84 +/- 23.25 ng/mL vs. 50.45 +/- 17.73; p < 0.001), independent of adjustment for age, sex, BMI, smoking and statin use. ANGPTL8 could also differentiate CAD patients from controls with 82.3% specificity and 81.4% sensitivity (p < 0.001). Adiponectin levels were lower in CAD patients, while ICAM-1, VCAM-1, TNF-alpha, IL6, and hsCRP levels were higher compared to non-CAD controls (all p < 0.001). ANGPTL8 levels were associated with BMI in controls and with BMI, TG, and ICAM-1 in CAD patients. The presence of elevated ANGPTL8 levels in CAD patients and independent association with TG and ICAM-1 suggest a possible role related to endothelial dysfunction in the pathogenesis of atherosclerosis.Funding Information
- Hamadan University of Medical Sciences
This publication has 51 references indexed in Scilit:
- Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesityScientific Reports, 2014
- Increased Circulating Betatrophin Concentrations in Patients with Type 2 DiabetesInternational Journal of Endocrinology, 2014
- ICAM-1: Isoforms and PhenotypesThe Journal of Immunology, 2014
- Adenovirus36 infection expresses cellular APMI and Visfatin genes in overweight Uygur individualsDiagnostic Pathology, 2014
- Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasisProceedings of the National Academy of Sciences of the United States of America, 2013
- Emerging roles of Lipasin as a critical lipid regulatorBiochemical and Biophysical Research Communications, 2013
- Atypical angiopoietin-like protein that regulates ANGPTL3Proceedings of the National Academy of Sciences of the United States of America, 2012
- Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levelsBiochemical and Biophysical Research Communications, 2012
- Community Prevalence of Ideal Cardiovascular Health, by the American Heart Association Definition, and Relationship With Cardiovascular Disease IncidenceJournal of the American College of Cardiology, 2011